James Celestin, MD
Pain Medicine · Worcester, MANPI 1508986084
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Boston Scientific at 53.6% of the total. Reporting peaked in 2020 at $5,056 and has fallen 95.0% since, to $252 in 2025.
Across 66 payments — averaging $163.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Medtronic$2K
- Nevro Corp.$2K
- Hydrocision, Inc.$500
- Abbott$171
- Painteq LLC$114
What the payments were for
- Consulting fees$4,50042%
- Travel & lodging$2,55524%
- Food & beverage$3,73835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $5,790 |
| Medtronic | 18 | $2,141 |
| Nevro Corp. | 21 | $2,077 |
| Hydrocision, Inc. | 1 | $500 |
| Abbott | 5 | $171 |
| Painteq LLC | 1 | $114 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$4,324
- Senza Spinal Cord Stimulation System$1,656
- INTELLIS ADAPTIVESTIM$1,583
- TenJet$500
- GENERAL PAIN MANAGEMENT$497
- GENERAL - THERAPIES$401
- INCEPTIV$153
- VANTA ADAPTIVESTIM$135
- Vanta$118
- GENERAL KIDNEY STONE DISEASE$116
- PROCLAIM$115
- PAINTEQ$114
How this compares
$10,793 in reported general payments places this provider in the 85th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 580 | $5,476 |
| Baclofen | 86 | $2,141 |
| Lidocaine | 23 | $640 |
| Topiramate | 23 | $551 |
| Meloxicam | 90 | $409 |
| Methocarbamol | 30 | $306 |
| Amitriptyline Hcl | 18 | $305 |
| Tizanidine Hcl | 24 | $301 |
| Diclofenac Sodium | 20 | $300 |
| Ibuprofen | 32 | $271 |
| Cyclobenzaprine Hcl | 41 | $236 |
| Pregabalin | 19 | $228 |
| Naproxen | 18 | $183 |
| Zonisamide | 14 | $177 |
| Methylprednisolone | 16 | $94 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Worcester
- Prashant KumarWorcester$6K
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Ivan UritsWareham$70K
- Antje BarreveldNewton$64K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Ali EbrahimiBurlington$41K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.